levofloxacin has been researched along with glucagon-like peptide 1 in 1 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (glucagon-like peptide 1) | Trials (glucagon-like peptide 1) | Recent Studies (post-2010) (glucagon-like peptide 1) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 9,484 | 1,208 | 6,374 |
Protein | Taxonomy | levofloxacin (IC50) | glucagon-like peptide 1 (IC50) |
---|---|---|---|
Glucagon-like peptide 1 receptor | Homo sapiens (human) | 0.0051 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, T; Imamura, Y; Ito, Y; Kikuchi, M; Shirasaki, Y | 1 |
1 other study(ies) available for levofloxacin and glucagon-like peptide 1
Article | Year |
---|---|
Validation studies on blood collection from the jugular vein of conscious mice.
Topics: Administration, Oral; Animal Welfare; Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Blood Glucose; Exenatide; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; Jugular Veins; Levofloxacin; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Ofloxacin; Peptides; Phlebotomy; Venoms | 2012 |